Clover Wolf Capital Limited Partnership - May 26, 2021 Form 4 Insider Report for PLURISTEM THERAPEUTICS INC (PLUR)

Role
10%+ Owner
Signature
Clover Wolf Capital - Limited Partnership By: Clover Wolf Ltd., its General Partner /s/ Adi Wolf, Chief Executive Officer and Managing Member
Stock symbol
PLUR
Transactions as of
May 26, 2021
Transactions value $
-$1,314,277
Form type
4
Date filed
6/1/2021, 07:34 AM
Previous filing
May 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLUR Common Stock Sale -$451K -123K -3.53% $3.68* 3.35M May 26, 2021 Direct F1
transaction PLUR Common Stock Sale -$81.2K -22K -0.66% $3.69* 3.33M May 26, 2021 Direct F2
transaction PLUR Common stock Sale -$265K -71.8K -2.15% $3.69* 3.26M May 27, 2021 Direct F3
transaction PLUR Common stock Sale -$89K -24.1K -0.74% $3.69* 3.24M May 27, 2021 Direct F4
transaction PLUR Common stock Sale -$260K -70K -2.16% $3.72* 3.17M May 28, 2021 Direct F5
transaction PLUR Common stock Sale -$167K -45K -1.42% $3.72* 3.12M May 28, 2021 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Clover Wolf Capital Limited Partnership is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.64 to $3.70 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.63 to $3.73 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.66 to $3.72 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.68 to $3.69 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.72 to $3.75 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.70 to $3.74 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.